Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TILT Sets First Quarter 2025 Conference Call for May 15 at 5:00 p.m. ET
-
CALIFORNIA BANCORP REPORTS NET INCOME OF $16.9 MILLION FOR THE FIRST QUARTER OF 2025
-
Thomas Barnes Joins Monarch Private Capital’s #Bestinclass Renewable Energy Team
-
American Oncology Network to Participate in 14 Sessions at 2025 Community Oncology Alliance Annual Conference
-
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
-
Tenneco Introduces Low Emission Brake Technology for Light and Commercial Vehicles
-
Coda Octopus Group Reports $1.4m Engineering Services Order
-
Australian Oilseeds Issues Annual Shareholder Letter
-
MISTRAS Group Launches MISTRAS Data Solutions Brand, Integrating Data-driven Capabilities for Customers Worldwide
-
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
-
Amid rising global supply chain risks, Sphera study highlights urgent need for enhanced N-Tier supply chain transparency
-
Crbon Labs and U.S. Venture Generate and Market Credits from Canadian Orphaned Gas Well
-
NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antim
-
Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH
-
Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025
-
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
-
Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies
-
Brera Holdings Portfolio Club Juve Stabia “The Second Team of Naples” Achieves Highest Market Value Increase in Serie B
-
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
-
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
-
NephroDI Therapeutics’ Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology
-
What to Do After an Accident: Miller & Jacobs Accident Attorneys Share Insights with HelloNation on Navigating Post-Crash Uncertainty
-
ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative R&D Trends for Inflammasome Inhibitors, and Provides Update on Inflammasome ASC Inhibitor IC 100’s Development Status
-
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
-
Wearable Devices Unveils Revolutionary Gesture Mapper for Mudra Link, Ushering in a New Era of Personalized Neural Control
-
AKVA group ASA: Invitation to Capital Markets Day 2025
-
ZenaTech’s ZenaDrone Granted FAA Part 137 Approval for Agricultural Drone Operations Addressing a $6 Billion Global Agricultural Drone Market Growing to $24 Billion by 2032
-
CoreCard Corporation Schedules First Quarter 2025 Earnings Release and Conference Call
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
-
Lifeist Relaunches Mikra with Bold New Branding, E-Commerce Website and Digital Strategy to Drive Revenue Growth
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™
-
FirstService Reports First Quarter Results
-
Applied Materials to Report Fiscal Second Quarter 2025 Results on May 15, 2025
-
Plato Gold Reports on 2024 Year-End Results
-
SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago
-
Global Crossing Airlines Sets First Quarter 2025 Conference Call for May 8, 2025 at 8:30 a.m. ET
-
Kura Oncology to Report First Quarter 2025 Financial Results
-
Kelly Announces First-Quarter 2025 Conference Call
-
TruGolf Improves Balance Sheet with Agreement to Eliminate All Convertible Notes
-
Super Hi Announces Annual General Meeting on June 24, 2025 and Filing of Its Annual Report on Form 20-F
-
Diginex and Baker Tilly Singapore Announce Strategic Alliance to Deliver diginexESG Platform to Baker Tilly ’s Clients
-
FTI Consulting Reports First Quarter 2025 Financial Results
-
Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
-
Amwell® to participate in upcoming investor conferences
-
SRM Entertainment Receives Six-Month Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement

